Journal article
Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank
Elizabeth Scarr, Mark J Millan, Sabine Bahn, Alessandro Bertolino, Christoph W Turck, Shitij Kapur, Hans-Juergen Moeller, Brian Dean
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | OXFORD UNIV PRESS | Published : 2015
DOI: 10.1093/ijnp/pyv042
Abstract
BACKGROUND: A think tank sponsored by the Collegium Internationale Neuropsychopharmacologium (CINP) debated the status and prospects of biological markers for psychiatric disorders, focusing on schizophrenia and major depressive disorder. METHODS: Discussions covered markers defining and predicting specific disorders or domains of dysfunction, as well as predicting and monitoring medication efficacy. Deliberations included clinically useful and viable biomarkers, why suitable markers are not available, and the need for tightly-controlled sample collection. RESULTS: Different types of biomarkers, appropriate sensitivity, specificity, and broad-based exploitability were discussed. Whilst a num..
View full abstractRelated Projects (1)
Grants
Awarded by Australian Research Council
Awarded by National Health and Medical Research Council
Awarded by Medical Research Council
Funding Acknowledgements
This work was supported by the Australian Research Council (FT100100689 to Dr Scarr), BMBF QuantPro grant and the Max Planck Society (Dr Turck), and the National Health and Medical Research Council (#APP1002240 to Dr Dean). The authors would like to thank all participants of the Think Tank 2013 for their stimulating discussions and insightful questions, particularly Professor Angelos Halaris for his cogent summation. The 2013 Think Tank was sponsored by the International College of Neuropsychopharmacology (CINP).